Cortexyme

+$0.10 (+3.23%) As of 12:39 PM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cortexyme and other ETFs, options, and stocks.

About CRTX

Cortexyme, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics. Its pipeline composed of COR388, COR588, COR788, COR822, and Coronavirus 3CL protease inhibitor.

CEO
Christopher P. Lowe
Employees
55
Headquarters
South San Francisco, California
Founded
2012

CRTX Key Statistics

Market cap
93.47M
Price-Earnings ratio
—
Dividend yield
—
Average volume
440.02K
High today
$3.46
Low today
$3.09
Open price
$3.30
Volume
447.25K
52 Week high
$121.98
52 Week low
$3.00

CRTX Earnings

-$0.78
-$0.52
-$0.26
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.55 per share
Actual
-$0.72 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure